Alcon | Latest News & Updates - Mar 27, 2025 Release
On March 26, 2025, Alcon acquired a majority interest in Aurion Biotech, Inc. to advance cell therapy for corneal endothelial disease, with Aurion's lead asset receiving Breakthrough Therapy and Regenerative Medicine Advanced Therapy Designations from the FDA...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following ๐ก


Alcon
๐ alcon.comAlcon is a global leader in eye care with over 75 years of heritage, dedicated to enhancing sight and improving lives through innovative vision products. The company offers a broad portfolio of surgical and vision care products that serve over 260 million people in more than 140 countries, addressing conditions such as cataracts, glaucoma, and refractive errors. With a workforce of over 25,000 associates, Alcon is committed to advancing access to quality eye care through partnerships and innovative solutions.
Alcon - Latest News and Updates
- On March 26, 2025, Alcon acquired a majority interest in Aurion Biotech, Inc. to advance cell therapy for corneal endothelial disease, with Aurion's lead asset receiving Breakthrough Therapy and Regenerative Medicine Advanced Therapy Designations from the FDA.
- Alcon's Dry Eye Wheel, a tool for diagnosing and treating dry eye disease, is now available in French.
- Alcon has agreed to acquire LENSAR, Inc. for approximately $356 million to enhance its cataract equipment and technology portfolio with LENSAR's advanced laser solutions.
- Alcon received CE Mark approval for Clareon Vivity IOL and will start its commercial rollout in Europe from early Q2 2025.
- Alcon's WaveLight Plus Ray-Trace Guided LASIK has received FDA approval for its personalized bladeless procedure.
- Alcon has been recognized as one of Singapore's Top 10 Best Workplaces in Healthcare & Biopharma for 2025.
- Charles Jones, PhD, MBA has joined Alcon as Senior Director, Pharma Program Management in the United States, previously serving as Sr. Director, Platform & Early Commercial Strategy Lead at Pfizer.
- Alcon recently opened a 7,500-square-foot Alcon Experience Center in Mexico to advance eye care through medical education.
- Carol from Alcon invites attendees to the Expo รptica 2025.
- Alcon is hiring an Associate for Sterile Production Operations in Huntington, West Virginia, to assist in planning and supervising daily production activities.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
